Published in Women's Health Weekly, January 19th, 2006
The basis for the product is the clinical research performed by Urex, the product development of Chr. Hansen and now the combined distribution capacity of both Chr Hansen and BioGaia.
The product is the world's first clinically documented oral probiotic product concept for restoring and maintaining a healthy vaginal flora. Maintaining a healthy vaginal flora may diminish the risk of acquiring urogenital infections such as bacterial vaginosis, yeast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly